Mouse strain differences in in vivo and in vitro immunosuppressive effects of opioids.
Eisenstein
T K
TK
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Meissler
J J
JJ
Bussiere
J L
JL
Rogers
T J
TJ
Geller
E B
EB
Adler
M W
MW
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D000818:Animals; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology; D005260:Female; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D018847:Opioid Peptides / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology; D013045:Species Specificity; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology
D007166:Immunosuppressive Agents; D018847:Opioid Peptides; D011759:Pyrrolidines; D009270:Naloxone; C051844:norbinaltorphimine; D009271:Naltrexone; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D009020:Morphine